Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2023-2029

Page: 112

Published Date: 30 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Pharmaceutical Development Preclinical CRO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Pharmaceutical Development Preclinical CRO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Development Preclinical CRO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical Development Preclinical CRO that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pharmaceutical Development Preclinical CRO total market, 2018-2029, (USD Million)
Global Pharmaceutical Development Preclinical CRO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical Development Preclinical CRO total market, key domestic companies and share, (USD Million)
Global Pharmaceutical Development Preclinical CRO revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical Development Preclinical CRO total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical Development Preclinical CRO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical Development Preclinical CRO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, Inc., ICON Plc., Pharmaron, Inotiv and ChemPartner, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical Development Preclinical CRO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pharmaceutical Development Preclinical CRO Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pharmaceutical Development Preclinical CRO Market, Segmentation by Type
    Bioanalysis and DMPK Studies
    Toxicology Testing
    Safety Pharmacology
    Others

Global Pharmaceutical Development Preclinical CRO Market, Segmentation by Application
    Small and Medium Pharmaceutical Company
    Large Pharmaceutical Company

Companies Profiled:
    Charles River
    Wuxi AppTec
    Labcorp
    Eurofins Scientific
    PPD, Inc.
    ICON Plc.
    Pharmaron
    Inotiv
    ChemPartner
    JOINN Lab
    EVOTEC
    Medicilon
    Crown Bioscience
    Champion Oncology

Key Questions Answered
1. How big is the global Pharmaceutical Development Preclinical CRO market?
2. What is the demand of the global Pharmaceutical Development Preclinical CRO market?
3. What is the year over year growth of the global Pharmaceutical Development Preclinical CRO market?
4. What is the total value of the global Pharmaceutical Development Preclinical CRO market?
5. Who are the major players in the global Pharmaceutical Development Preclinical CRO market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Pharmaceutical Development Preclinical CRO Introduction
    1.2 World Pharmaceutical Development Preclinical CRO Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Pharmaceutical Development Preclinical CRO Total Market by Region (by Headquarter Location)
        1.3.1 World Pharmaceutical Development Preclinical CRO Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Pharmaceutical Development Preclinical CRO Market Size (2018-2029)
        1.3.3 China Pharmaceutical Development Preclinical CRO Market Size (2018-2029)
        1.3.4 Europe Pharmaceutical Development Preclinical CRO Market Size (2018-2029)
        1.3.5 Japan Pharmaceutical Development Preclinical CRO Market Size (2018-2029)
        1.3.6 South Korea Pharmaceutical Development Preclinical CRO Market Size (2018-2029)
        1.3.7 ASEAN Pharmaceutical Development Preclinical CRO Market Size (2018-2029)
        1.3.8 India Pharmaceutical Development Preclinical CRO Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pharmaceutical Development Preclinical CRO Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pharmaceutical Development Preclinical CRO Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)
    2.2 World Pharmaceutical Development Preclinical CRO Consumption Value by Region
        2.2.1 World Pharmaceutical Development Preclinical CRO Consumption Value by Region (2018-2023)
        2.2.2 World Pharmaceutical Development Preclinical CRO Consumption Value Forecast by Region (2024-2029)
    2.3 United States Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)
    2.4 China Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)
    2.5 Europe Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)
    2.6 Japan Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)
    2.7 South Korea Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)
    2.8 ASEAN Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)
    2.9 India Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029)

3 World Pharmaceutical Development Preclinical CRO Companies Competitive Analysis
    3.1 World Pharmaceutical Development Preclinical CRO Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Pharmaceutical Development Preclinical CRO Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical Development Preclinical CRO in 2022
        3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical Development Preclinical CRO in 2022
    3.3 Pharmaceutical Development Preclinical CRO Company Evaluation Quadrant
    3.4 Pharmaceutical Development Preclinical CRO Market: Overall Company Footprint Analysis
        3.4.1 Pharmaceutical Development Preclinical CRO Market: Region Footprint
        3.4.2 Pharmaceutical Development Preclinical CRO Market: Company Product Type Footprint
        3.4.3 Pharmaceutical Development Preclinical CRO Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Pharmaceutical Development Preclinical CRO Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Pharmaceutical Development Preclinical CRO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Pharmaceutical Development Preclinical CRO Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Pharmaceutical Development Preclinical CRO Consumption Value Comparison
        4.2.1 United States VS China: Pharmaceutical Development Preclinical CRO Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Pharmaceutical Development Preclinical CRO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Pharmaceutical Development Preclinical CRO Companies and Market Share, 2018-2023
        4.3.1 United States Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2018-2023)
    4.4 China Based Companies Pharmaceutical Development Preclinical CRO Revenue and Market Share, 2018-2023
        4.4.1 China Based Pharmaceutical Development Preclinical CRO Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2018-2023)
    4.5 Rest of World Based Pharmaceutical Development Preclinical CRO Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Pharmaceutical Development Preclinical CRO Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Bioanalysis and DMPK Studies
        5.2.2 Toxicology Testing
        5.2.3 Safety Pharmacology
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023)
        5.3.2 World Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2029)
        5.3.3 World Pharmaceutical Development Preclinical CRO Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Pharmaceutical Development Preclinical CRO Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Small and Medium Pharmaceutical Company
        6.2.2 Large Pharmaceutical Company
    6.3 Market Segment by Application
        6.3.1 World Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023)
        6.3.2 World Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2029)
        6.3.3 World Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Charles River
        7.1.1 Charles River Details
        7.1.2 Charles River Major Business
        7.1.3 Charles River Pharmaceutical Development Preclinical CRO Product and Services
        7.1.4 Charles River Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Charles River Recent Developments/Updates
        7.1.6 Charles River Competitive Strengths & Weaknesses
    7.2 Wuxi AppTec
        7.2.1 Wuxi AppTec Details
        7.2.2 Wuxi AppTec Major Business
        7.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Services
        7.2.4 Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Wuxi AppTec Recent Developments/Updates
        7.2.6 Wuxi AppTec Competitive Strengths & Weaknesses
    7.3 Labcorp
        7.3.1 Labcorp Details
        7.3.2 Labcorp Major Business
        7.3.3 Labcorp Pharmaceutical Development Preclinical CRO Product and Services
        7.3.4 Labcorp Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Labcorp Recent Developments/Updates
        7.3.6 Labcorp Competitive Strengths & Weaknesses
    7.4 Eurofins Scientific
        7.4.1 Eurofins Scientific Details
        7.4.2 Eurofins Scientific Major Business
        7.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Services
        7.4.4 Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Eurofins Scientific Recent Developments/Updates
        7.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
    7.5 PPD, Inc.
        7.5.1 PPD, Inc. Details
        7.5.2 PPD, Inc. Major Business
        7.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Services
        7.5.4 PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 PPD, Inc. Recent Developments/Updates
        7.5.6 PPD, Inc. Competitive Strengths & Weaknesses
    7.6 ICON Plc.
        7.6.1 ICON Plc. Details
        7.6.2 ICON Plc. Major Business
        7.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Product and Services
        7.6.4 ICON Plc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 ICON Plc. Recent Developments/Updates
        7.6.6 ICON Plc. Competitive Strengths & Weaknesses
    7.7 Pharmaron
        7.7.1 Pharmaron Details
        7.7.2 Pharmaron Major Business
        7.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Product and Services
        7.7.4 Pharmaron Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Pharmaron Recent Developments/Updates
        7.7.6 Pharmaron Competitive Strengths & Weaknesses
    7.8 Inotiv
        7.8.1 Inotiv Details
        7.8.2 Inotiv Major Business
        7.8.3 Inotiv Pharmaceutical Development Preclinical CRO Product and Services
        7.8.4 Inotiv Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Inotiv Recent Developments/Updates
        7.8.6 Inotiv Competitive Strengths & Weaknesses
    7.9 ChemPartner
        7.9.1 ChemPartner Details
        7.9.2 ChemPartner Major Business
        7.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Product and Services
        7.9.4 ChemPartner Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 ChemPartner Recent Developments/Updates
        7.9.6 ChemPartner Competitive Strengths & Weaknesses
    7.10 JOINN Lab
        7.10.1 JOINN Lab Details
        7.10.2 JOINN Lab Major Business
        7.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Product and Services
        7.10.4 JOINN Lab Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 JOINN Lab Recent Developments/Updates
        7.10.6 JOINN Lab Competitive Strengths & Weaknesses
    7.11 EVOTEC
        7.11.1 EVOTEC Details
        7.11.2 EVOTEC Major Business
        7.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Product and Services
        7.11.4 EVOTEC Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 EVOTEC Recent Developments/Updates
        7.11.6 EVOTEC Competitive Strengths & Weaknesses
    7.12 Medicilon
        7.12.1 Medicilon Details
        7.12.2 Medicilon Major Business
        7.12.3 Medicilon Pharmaceutical Development Preclinical CRO Product and Services
        7.12.4 Medicilon Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Medicilon Recent Developments/Updates
        7.12.6 Medicilon Competitive Strengths & Weaknesses
    7.13 Crown Bioscience
        7.13.1 Crown Bioscience Details
        7.13.2 Crown Bioscience Major Business
        7.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Services
        7.13.4 Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Crown Bioscience Recent Developments/Updates
        7.13.6 Crown Bioscience Competitive Strengths & Weaknesses
    7.14 Champion Oncology
        7.14.1 Champion Oncology Details
        7.14.2 Champion Oncology Major Business
        7.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Product and Services
        7.14.4 Champion Oncology Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Champion Oncology Recent Developments/Updates
        7.14.6 Champion Oncology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pharmaceutical Development Preclinical CRO Industry Chain
    8.2 Pharmaceutical Development Preclinical CRO Upstream Analysis
    8.3 Pharmaceutical Development Preclinical CRO Midstream Analysis
    8.4 Pharmaceutical Development Preclinical CRO Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pharmaceutical Development Preclinical CRO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Pharmaceutical Development Preclinical CRO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Pharmaceutical Development Preclinical CRO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Pharmaceutical Development Preclinical CRO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Pharmaceutical Development Preclinical CRO Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Pharmaceutical Development Preclinical CRO Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Pharmaceutical Development Preclinical CRO Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Pharmaceutical Development Preclinical CRO Players in 2022
    Table 12. World Pharmaceutical Development Preclinical CRO Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Pharmaceutical Development Preclinical CRO Company Evaluation Quadrant
    Table 14. Head Office of Key Pharmaceutical Development Preclinical CRO Player
    Table 15. Pharmaceutical Development Preclinical CRO Market: Company Product Type Footprint
    Table 16. Pharmaceutical Development Preclinical CRO Market: Company Product Application Footprint
    Table 17. Pharmaceutical Development Preclinical CRO Mergers & Acquisitions Activity
    Table 18. United States VS China Pharmaceutical Development Preclinical CRO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Pharmaceutical Development Preclinical CRO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Pharmaceutical Development Preclinical CRO Revenue Market Share (2018-2023)
    Table 23. China Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Pharmaceutical Development Preclinical CRO Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Pharmaceutical Development Preclinical CRO Revenue Market Share (2018-2023)
    Table 29. World Pharmaceutical Development Preclinical CRO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Pharmaceutical Development Preclinical CRO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2029) & (USD Million)
    Table 35. Charles River Basic Information, Area Served and Competitors
    Table 36. Charles River Major Business
    Table 37. Charles River Pharmaceutical Development Preclinical CRO Product and Services
    Table 38. Charles River Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Charles River Recent Developments/Updates
    Table 40. Charles River Competitive Strengths & Weaknesses
    Table 41. Wuxi AppTec Basic Information, Area Served and Competitors
    Table 42. Wuxi AppTec Major Business
    Table 43. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Services
    Table 44. Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Wuxi AppTec Recent Developments/Updates
    Table 46. Wuxi AppTec Competitive Strengths & Weaknesses
    Table 47. Labcorp Basic Information, Area Served and Competitors
    Table 48. Labcorp Major Business
    Table 49. Labcorp Pharmaceutical Development Preclinical CRO Product and Services
    Table 50. Labcorp Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Labcorp Recent Developments/Updates
    Table 52. Labcorp Competitive Strengths & Weaknesses
    Table 53. Eurofins Scientific Basic Information, Area Served and Competitors
    Table 54. Eurofins Scientific Major Business
    Table 55. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Services
    Table 56. Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Eurofins Scientific Recent Developments/Updates
    Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
    Table 59. PPD, Inc. Basic Information, Area Served and Competitors
    Table 60. PPD, Inc. Major Business
    Table 61. PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Services
    Table 62. PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. PPD, Inc. Recent Developments/Updates
    Table 64. PPD, Inc. Competitive Strengths & Weaknesses
    Table 65. ICON Plc. Basic Information, Area Served and Competitors
    Table 66. ICON Plc. Major Business
    Table 67. ICON Plc. Pharmaceutical Development Preclinical CRO Product and Services
    Table 68. ICON Plc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. ICON Plc. Recent Developments/Updates
    Table 70. ICON Plc. Competitive Strengths & Weaknesses
    Table 71. Pharmaron Basic Information, Area Served and Competitors
    Table 72. Pharmaron Major Business
    Table 73. Pharmaron Pharmaceutical Development Preclinical CRO Product and Services
    Table 74. Pharmaron Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Pharmaron Recent Developments/Updates
    Table 76. Pharmaron Competitive Strengths & Weaknesses
    Table 77. Inotiv Basic Information, Area Served and Competitors
    Table 78. Inotiv Major Business
    Table 79. Inotiv Pharmaceutical Development Preclinical CRO Product and Services
    Table 80. Inotiv Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Inotiv Recent Developments/Updates
    Table 82. Inotiv Competitive Strengths & Weaknesses
    Table 83. ChemPartner Basic Information, Area Served and Competitors
    Table 84. ChemPartner Major Business
    Table 85. ChemPartner Pharmaceutical Development Preclinical CRO Product and Services
    Table 86. ChemPartner Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. ChemPartner Recent Developments/Updates
    Table 88. ChemPartner Competitive Strengths & Weaknesses
    Table 89. JOINN Lab Basic Information, Area Served and Competitors
    Table 90. JOINN Lab Major Business
    Table 91. JOINN Lab Pharmaceutical Development Preclinical CRO Product and Services
    Table 92. JOINN Lab Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. JOINN Lab Recent Developments/Updates
    Table 94. JOINN Lab Competitive Strengths & Weaknesses
    Table 95. EVOTEC Basic Information, Area Served and Competitors
    Table 96. EVOTEC Major Business
    Table 97. EVOTEC Pharmaceutical Development Preclinical CRO Product and Services
    Table 98. EVOTEC Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. EVOTEC Recent Developments/Updates
    Table 100. EVOTEC Competitive Strengths & Weaknesses
    Table 101. Medicilon Basic Information, Area Served and Competitors
    Table 102. Medicilon Major Business
    Table 103. Medicilon Pharmaceutical Development Preclinical CRO Product and Services
    Table 104. Medicilon Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Medicilon Recent Developments/Updates
    Table 106. Medicilon Competitive Strengths & Weaknesses
    Table 107. Crown Bioscience Basic Information, Area Served and Competitors
    Table 108. Crown Bioscience Major Business
    Table 109. Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Services
    Table 110. Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Crown Bioscience Recent Developments/Updates
    Table 112. Champion Oncology Basic Information, Area Served and Competitors
    Table 113. Champion Oncology Major Business
    Table 114. Champion Oncology Pharmaceutical Development Preclinical CRO Product and Services
    Table 115. Champion Oncology Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Pharmaceutical Development Preclinical CRO Upstream (Raw Materials)
    Table 117. Pharmaceutical Development Preclinical CRO Typical Customers
List of Figure
    Figure 1. Pharmaceutical Development Preclinical CRO Picture
    Figure 2. World Pharmaceutical Development Preclinical CRO Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Pharmaceutical Development Preclinical CRO Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Pharmaceutical Development Preclinical CRO Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Pharmaceutical Development Preclinical CRO Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Pharmaceutical Development Preclinical CRO Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Pharmaceutical Development Preclinical CRO Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Pharmaceutical Development Preclinical CRO Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Pharmaceutical Development Preclinical CRO Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Pharmaceutical Development Preclinical CRO Revenue (2018-2029) & (USD Million)
    Figure 13. Pharmaceutical Development Preclinical CRO Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Pharmaceutical Development Preclinical CRO Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Pharmaceutical Development Preclinical CRO by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical Development Preclinical CRO Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical Development Preclinical CRO Markets in 2022
    Figure 27. United States VS China: Pharmaceutical Development Preclinical CRO Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Pharmaceutical Development Preclinical CRO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Pharmaceutical Development Preclinical CRO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Pharmaceutical Development Preclinical CRO Market Size Market Share by Type in 2022
    Figure 31. Bioanalysis and DMPK Studies
    Figure 32. Toxicology Testing
    Figure 33. Safety Pharmacology
    Figure 34. Others
    Figure 35. World Pharmaceutical Development Preclinical CRO Market Size Market Share by Type (2018-2029)
    Figure 36. World Pharmaceutical Development Preclinical CRO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Pharmaceutical Development Preclinical CRO Market Size Market Share by Application in 2022
    Figure 38. Small and Medium Pharmaceutical Company
    Figure 39. Large Pharmaceutical Company
    Figure 40. Pharmaceutical Development Preclinical CRO Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Pharmaceutical Development Preclinical CRO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Pharmaceutical Development Preclinical CRO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 03 Jun 2022

date Medical Care

The Pharmaceutical Development Preclinical CRO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Pharmaceutical Development Preclinical CRO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Pharmaceutical Development Preclinical CRO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Pharmaceutical Development Preclinical CRO market size was valued at USD 11870 million in 2023 and is forecast to a readjusted size of USD 19910 million by 2030 with a CAGR of 7.7% during review period.

Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2024-2030

Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2024-2030

date 17 Feb 2024

date Medical Care

The global Pharmaceutical Development Preclinical CRO market size is expected to reach $ 19910 million by 2030, rising at a market growth of 7.7% CAGR during the forecast period (2024-2030).

Product Tags

pharmaceutical development preclinical cro

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>